Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03232333 · ClinicalTrials.gov registry record
MIRODERM H2H DFU Study
A clinical trial, sponsored by Miromatrix Medical.
- Completed
- Registry status
- 53
- Enrollment target
NCT03232333 is a clinical trial that has completed, run by Miromatrix Medical. The registered enrollment target is 53 participants.
The verdict
NCT03232333 has completed, sponsored by Miromatrix Medical.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
This study will assess the ability of MIRODERM to heal difficult diabetic foot ulcers within 12 weeks of treatment.
Interventions
- DEVICE Biologic wound graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2017-07-21 |
| Est. Completion | 2018-09-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03232333
The ClinicalTrials.gov registry entry for NCT03232333 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Miromatrix Medical, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Biologic wound graft is the first listed.
NCT03232333 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03232333 about?
NCT03232333 is a clinical study titled "MIRODERM H2H DFU Study". This study will assess the ability of MIRODERM to heal difficult diabetic foot ulcers within 12 weeks of treatment.
What is the current status of trial NCT03232333?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2017-07-21. Estimated completion is 2018-09-20.
What interventions are being tested in trial NCT03232333?
The interventions under investigation include: Biologic wound graft (DEVICE).
Who is sponsoring clinical trial NCT03232333?
This trial is sponsored by Miromatrix Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.